SB 68Session 2025
Relating to: the prescription drug monitoring program. (FE)
Progress
- Introduced
- In committee
- Passed Senate
- Passed legislature
- Sent to governor
- Became law
What this bill would cost
Fiscal notes are prepared by the state’s budget staff and reflect the bill as written at the time.
Votes
-
Report passage recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 5, Noes 0
5 yes0 no
Legislative history
-
Senate
Published 3-29-2025
-
Senate
Report approved by the Governor on 3-28-2025. 2025 Wisconsin Act 5
-
Senate
Presented to the Governor on 3-24-2025
-
Senate
Report correctly enrolled
-
Senate
Received from Assembly concurred in
-
House
Ordered immediately messaged
-
House
Read a third time and concurred in
-
House
Rules suspended
-
House
Ordered to a third reading
-
House
Read a second time
-
House
Rules suspended to withdraw from calendar and take up
-
House
Placed on calendar 3-20-2025 by Committee on Rules
-
House
Read first time and referred to committee on Rules
-
House
Received from Senate
-
Senate
Ordered immediately messaged
-
Senate
Read a third time and passed
-
Senate
Rules suspended to give bill its third reading
-
Senate
Ordered to a third reading
-
Senate
Read a second time
-
Senate
Placed on calendar 3-18-2025 pursuant to Senate Rule 18(1)
-
Senate
Representative Subeck added as a cosponsor
-
Senate
Representatives Stubbs and Moore Omokunde added as cosponsors
-
Senate
Available for scheduling
-
Senate
Report passage recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 5, Noes 0
-
Senate
Executive action taken
-
Senate
Public hearing held
-
Senate
Fiscal estimate received
-
Senate
Read first time and referred to Committee on Mental Health, Substance Abuse Prevention, Children and Families
-
Senate
Introduced by Senator Testin; cosponsored by Representative Dittrich